DiaMedica Therapeutics Inc (DMAC) — Cash Flow Reinvestment Rate
Latest as of September 2010:
0.03x
DiaMedica Therapeutics Inc (DMAC) has a Cash Flow Reinvestment Rate of 0.03x as of September 2010, reinvesting $11.57K (capex $11.57K ) from operating cash flow of $392.76K. Explore DiaMedica Therapeutics Inc (DMAC) cash flow conversion to assess how effectively this company generates cash.
Reinvestment Rate
0.03x
(Capex + Investments) / Operating CF
Total Reinvested
$11.57K
Capex + Investments
Operating Cash Flow
$392.76K
USD
Capital Expenditures
$11.57K
USD
Annual Cash Flow Reinvestment Rate for DiaMedica Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for DiaMedica Therapeutics Inc. For live market cap and broader valuation context, see DiaMedica Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow